Acute Pancreatitis After the Use of Belimumab in a Patient With Systemic Lupus Erythematosus: Case Report and Review of Literature

Belimumab is a B-cell depletion therapy that has emerged as an effective and safe treatment option for Systemic Lupus Erythematosus (SLE), but ongoing phase IV trials continue to report its common and rare adverse effects. Our case report seeks to add data to the existing literature on the safety pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazigh, Izza, Asfour, Mohamad, Muddassir, Salman, Mughni, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956404/
https://www.ncbi.nlm.nih.gov/pubmed/35345744
http://dx.doi.org/10.7759/cureus.22540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956404/
https://www.ncbi.nlm.nih.gov/pubmed/35345744
http://dx.doi.org/10.7759/cureus.22540

Ejemplares similares